A Study to Learn About Study Medicine Called PF-07261271 in Healthy People

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

The purpose of this clinical trial is to learn about the safety and effects of the study medicine PF-07261271 for the potential treatment of Inflammatory Bowel Disease.

Key facts

Study ID

NCT05536440

Run by

Pfizer

People needed

35

Starts

2022-10-17

Expected to finish

2024-02-29

Last updated by the study team

2025-03-24

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy individuals as determined by medical evaluation
• Body mass index (BMI) of 17.5 to 30.5 kg/m2; and a total body weight >50 kg (110 lb).

You may not qualify if…

• Clinically significant medical conditions
• History of HIV infection, hepatitis B, or hepatitis C
• BP ≥140 mm Hg (systolic) or ≥90 mm Hg (diastolic)
• Clinically relevant ECG abnormalities
• Previous study drug administration within 30 days or 5 half-lives of first planned dose
• History of drug/alcohol abuse or >20 cigarettes/day

Where it is running

• Orange County Research Center — Lake Forest, California, United States
• Orange County Research Center — Tustin, California, United States
• Clinilabs — Eatontown, New Jersey, United States
• ICON — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.